Product Information
ASMANEX HFA 50 MCG INHALER is a brand product labeled by Organon LLC, priced at $6.8392 per GM under NDC 78206011101. Its NADAC has been published 261 times since Oct 6, 2021.
FDA first approved this application on Apr 25, 2014.
The High Outlier badge above means this manufacturer's average price in the MOMETASONE FUROATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 ug/1
Manufacturer
Organon LLCNDC
78206011101
Classification
Brand
Dosage Form
AEROSOL
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA205641FDA Approved
4/25/2014
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ASMANEX HFA 50 MCG INHALER has been published 261 times since Oct 6, 2021, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8392 per GM |
|---|---|
| All-time high | $13.8049 (Jan 3, 2024) |
| All-time low | $6.8392 (Sep 23, 2026) |
| 52-week high | $6.8498 |
| 52-week low | $6.8392 |
| Median price | $6.9024 |
| Average price | $9.9305 |
| Largest weekly change | -50.0% (Jan 10, 2024) |
| Weeks tracked | 261 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MOMETASONE FUROATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MOMETASONE FUROATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASMANEX HFA 50 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for ASMANEX HFA 50 MCG INHALER, manufactured by Organon LLC, is $6.8392 per GM (NDC 78206011101), effective Sep 30, 2026.
How has the price of ASMANEX HFA 50 MCG INHALER changed over time?
Over the history we have for it, the NADAC for ASMANEX HFA 50 MCG INHALER has declined 47.5%. It has been tracked across 261 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for ASMANEX HFA 50 MCG INHALER?
Since Oct 6, 2021, the NADAC for ASMANEX HFA 50 MCG INHALER has ranged from a low of $6.8392 (Sep 23, 2026) to a high of $13.8049 (Jan 3, 2024), with a median of $6.9024 per GM.
Are there cheaper alternatives to ASMANEX HFA 50 MCG INHALER?
No other NADAC-published product currently shares the active ingredient and strength of ASMANEX HFA 50 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASMANEX HFA 50 MCG INHALER?
ASMANEX HFA 50 MCG INHALER (NDC 78206011101) is labeled by Organon LLC, and CMS classifies it as a brand product.